{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:06:01Z","timestamp":1790697961654,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","nucmedbio.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.nucmedbio.2015.07.012","type":"journal-article","created":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T12:36:03Z","timestamp":1438432563000},"page":"73-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Development of [ 64 Cu]-DOTA-PR81 radioimmunoconjugate for MUC-1 positive PET imaging"],"prefix":"10.1016","volume":"43","author":[{"given":"Behrouz","family":"Alirezapour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Javad","family":"Rasaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Reza","family":"Jalilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Rajabifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Mohammadnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malihe","family":"Paknejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Maadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedigheh","family":"Moradkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0005","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.nucmedbio.2009.01.001","article-title":"A simplified suite of methods to evaluate chelator conjugation of antibodies: effects on hydrodynamic radius and biodistribution","volume":"36","author":"Al-Ejeh","year":"2009","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00262-002-0348-5","article-title":"Advancing role of radiolabeled antibodies in the therapy of cancer","volume":"52","author":"Goldenberg","year":"2003","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0015","first-page":"693","article-title":"Targeted therapy of cancer with radiolabeled antibodies","volume":"43","author":"Goldenberg","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/cmmi.1627","article-title":"Monoclonal antibody conjugated magnetic nanoparticles could target MUC\u20101\u2010positive cells in vitro but not in vivo","volume":"10","author":"Shanehsazzadeh","year":"2014","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0025","doi-asserted-by":"crossref","first-page":"12820","DOI":"10.1016\/S0021-9258(18)37632-4","article-title":"A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats","volume":"263","author":"Gendler","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0030","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1158\/0008-5472.CAN-03-3230","article-title":"In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe","volume":"64","author":"Moore","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0301-2115(98)00302-9","article-title":"Quantification of MUC1 in breast cancer patients: a method comparison study","volume":"83","author":"Bon","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"Pt 5","key":"10.1016\/j.nucmedbio.2015.07.012_bb0040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1177\/000456329903600503","article-title":"CA 15-3 and related mucins as circulating markers in breast cancer","volume":"36","author":"Duffy","year":"1999","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1040-8428(00)00136-0","article-title":"Systemic radiotherapy in metastatic breast cancer using 90 Y-linked monoclonal MUC-1 antibodies","volume":"38","author":"Richman","year":"2001","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0050","first-page":"103","article-title":"Monoclonal antibodies: old and new trends in breast cancer imaging and therapeutic approach","volume":"8","author":"Stipsanelli","year":"2004","journal-title":"Hell J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0055","first-page":"304","article-title":"Development of anti-MUC1 di-scFvs for molecular targeting of epithelial cancers, such as breast and prostate cancers","volume":"51","author":"Albrecht","year":"2007","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11523-009-0119-8","article-title":"Imaging in targeted delivery of therapy to cancer","volume":"4","author":"Dancey","year":"2009","journal-title":"Target Oncol"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/153685903322286566","article-title":"Production of monoclonal antibody, PR81, recognizing the tandem repeat region of MUC1 mucin","volume":"22","author":"Paknejad","year":"2003","journal-title":"Hybrid Hybridomics"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0070","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.nucmedbio.2008.07.002","article-title":"Breast tumor targeting with 99m Tc-HYNIC-PR81 complex as a new biologic radiopharmaceutical","volume":"35","author":"Salouti","year":"2008","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12149-010-0434-2","article-title":"Comparison of 99mTc-labeled PR81 and its F (ab\u2032) 2 fragments as radioimmunoscintigraphy agents for breast cancer imaging","volume":"25","author":"Salouti","year":"2011","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/HAB-2010-0216","article-title":"Radioimmunotherapy of MCF7 breast cancer cell line with^{131} I-PR81 monoclonal antibody against MUC1: comparison of direct and indirect radioiodination methods","volume":"19","author":"Mohammadnejad","year":"2010","journal-title":"Hum Antibodies"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0085","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.nucmedbio.2011.02.009","article-title":"Preparation and biological evaluation of 177Lu conjugated PR81 for radioimmunotherapy of breast cancer","volume":"38","author":"Salouti","year":"2011","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0090","series-title":"Proceedings of the 9th International Symposium on Capture gamma-ray spectroscopy and related topics. V. 2","article-title":"The 8th edition of the table of isotopes","author":"Firestone","year":"1997"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0095","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0969-8051(03)00033-7","article-title":"Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N, N', N\", N\"'-tetraacetic acid for radiolabeling proteins","volume":"30","author":"Chappell","year":"2003","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0100","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0969-8043(02)00167-7","article-title":"Design and synthesis of 225 Ac radioimmunopharmaceuticals","volume":"57","author":"McDevitt","year":"2002","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0969-8051(02)00391-8","article-title":"Radiochemical investigations of 177 Lu-DOTA-8-Aoc-BBN [7\u201314] NH 2: an in vitro\/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells","volume":"30","author":"Smith","year":"2003","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0969-8051(99)00086-4","article-title":"Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes 203 Pb and 212 Pb","volume":"27","author":"Chappell","year":"2000","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0115","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s10967-012-1939-z","article-title":"Optimized preparation and preliminary evaluation of [64Cu]-DOTA-trastuzumab for targeting ErbB2\/Neu expression","volume":"295","author":"Alirezapour","year":"2013","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/BA20040121","article-title":"Continuous production of monoclonal antibody in a packed-bed bioreactor","volume":"41","author":"Golmakany","year":"2005","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0125","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1021\/bc00016a014","article-title":"Spectrophotometric method for the determination of a bifunctional DTPA ligand in DTPA-monoclonal antibody conjugates","volume":"3","author":"Pippin","year":"1992","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0022-1759(84)90435-6","article-title":"Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess","volume":"72","author":"Lindmo","year":"1984","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0135","first-page":"1","article-title":"Antibody transport and internalization into tumours","volume":"10","author":"Matzku","year":"1990","journal-title":"Br J Cancer Suppl"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0140","first-page":"878","article-title":"Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates","volume":"55","author":"Kukis","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0145","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0969-8051(03)00019-2","article-title":"Targeting of renal carcinoma with 67\/64 Cu-labeled anti-L1-CAM antibody chCE7: selection of copper ligands and PET imaging","volume":"30","author":"Zimmermann","year":"2003","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0150","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1089\/10849780152752083","article-title":"Conjugation of monoclonal antibodies with TETA using activated esters: biological comparison of 64Cu-TETA-1A3 with 64Cu-BAT-2IT-1A3","volume":"16","author":"Lewis","year":"2001","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0155","first-page":"363","article-title":"Serum stability of 67 Cu chelates: comparison with 111 In and 57 Co. International Journal of Radiation Applications and Instrumentation. Part B","volume":"13","author":"Cole","year":"1986","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0160","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1021\/bc300037w","article-title":"Comparison of 64Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro\/in vivo stability","volume":"23","author":"Cooper","year":"2012","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0165","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2967\/jnumed.106.037937","article-title":"111In-labeled trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): an Auger electron-emitting radiotherapeutic agent for HER2\/neu-amplified breast cancer","volume":"48","author":"Costantini","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0170","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/bc990167l","article-title":"In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver","volume":"11","author":"Bass","year":"2000","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0175","doi-asserted-by":"crossref","first-page":"54802","DOI":"10.1074\/jbc.M410854200","article-title":"Identification of the transmembrane metal binding site in Cu+-transporting PIB-type ATPases","volume":"279","author":"Mandal","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nucmedbio.2015.07.012_bb0180","first-page":"4453","article-title":"Radioiodination via D-amino acid peptide enhances cellular retention and tumor xenograft targeting of an internalizing anti-epidermal growth factor receptor variant III monoclonal antibody","volume":"60","author":"Foulon","year":"2000","journal-title":"Cancer Res"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805115001341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805115001341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T20:55:51Z","timestamp":1652993751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805115001341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0969805115001341"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2015.07.012","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of [64Cu]-DOTA-PR81 radioimmunoconjugate for MUC-1 positive PET imaging","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2015.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}